Patents by Inventor Hong Jae JEON

Hong Jae JEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PROVIDING THE INFORMATION FOR DIAGNOSING OF NONALCOHOLIC STEATOHEPATITIS
    Publication number: 20240341708
    Abstract: Provided is a method for providing the information for diagnosing nonalcoholic steatohepatitis.
    Type: Application
    Filed: March 25, 2024
    Publication date: October 17, 2024
    Applicant: CHUNGNAM NATIONAL UNIVERSITY HOSPITAL
    Inventors: Hyuk Soo EUN, Hong Jae JEON, Ha Neul KIM
  • IMMUNO-ONCOLOGY THERAPEUTIC COMPOSITION USING ADJUVANT INCLUDING LIPOPEPTIDES AND POLY (I:C)
    Publication number: 20240277754
    Abstract: An immuno-oncology therapeutic composition containing, as an active ingredient, an adjuvant including lipopeptides and poly (I:C) provided in one aspect of the present invention can induce a large therapeutic effect on a variety of carcinomas, and can be effectively used for anticancer therapy by significantly enhancing anticancer effects through combined administration with conventional anticancer drugs, such as chemical anticancer drugs, anticancer vaccines, and immune checkpoint inhibitors, having different mechanisms.
    Type: Application
    Filed: May 24, 2022
    Publication date: August 22, 2024
    Applicant: CHA VACCINE RESEARCH INSTITUTE CO., LTD
    Inventors: Jung Sun Yum, Jungki Cho, Byung Cheol Ahn, Sookyung Jeong, Yoonki Heo, Hong Jae Jeon, Chan Kim
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
    Publication number: 20230241141
    Abstract: Provided are a pharmaceutical composition including reovirus or reovirus-treated biological sample as an active ingredient for prevention or treatment of cancer, and a method for prevention or treatment of cancer using same. In addition, provided are a combination use of the pharmaceutical composition and an immune checkpoint inhibitor for treatment of cancer.
    Type: Application
    Filed: April 7, 2021
    Publication date: August 3, 2023
    Applicant: VIROCURE, INC.
    Inventors: Haeng Jun YOO, Sang Kyoung HAN, Yeon Sook LEE, Chan KIM, Hong Jae JEON
  • IDO-TDO dual inhibitor and related methods of use
    Patent number: 11370758
    Abstract: Provided is an inhibitor of an indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) of formula (I) or a pharmaceutically acceptable salt thereof: in which W1, W2, W3, and W4, X, Y, Z1, Z2, and R1-7 are described herein. Further provided is a method of treating or preventing a IDO and/or TDO-mediated disease using an effective amount of the compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 28, 2022
    Assignees: CMG PHARMACEUTICAL CO., LTD., SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hong Jae Jeon, Chan Kim, Na Keum Lee, Jin Sung Kim, Hye Sun Jeon, Young Eun Kwon, Ju Hui Jeong
  • IDO-TDO DUAL INHIBITOR AND RELATED METHODS OF USE
    Publication number: 20190292150
    Abstract: Provided is an inhibitor of an indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) of formula (I) or a pharmaceutically acceptable salt thereof: in which W1, W2, W3, and W4, X, Y, Z1, Z2, and R1-7 are described herein. Further provided is a method of treating or preventing a IDO and/or TDO-mediated disease using an effective amount of the compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Applicants: CMG PHARMACEUTICAL CO., LTD., SUNGKWANG MEDICAL FOUNDATION
    Inventors: Hong Jae JEON, Chan KIM, Na Keum LEE, Jin Sung KIM, Hye Sun JEON, Young Eun KWON, Ju Hui JEONG